AstraZeneca gets CDSCO nod to import and market critical anti-bleeding drug in India
City-based AstraZeneca Pharma India Ltd., biopharmaceutical firm, on Tuesday said it has received approval from Central Drugs Standard Control Organisation (CDSCO) for importing and marketing of Andexanet Alfa in India. Andexanet Alfa is a novel and life-saving antidote designed to reverse the effects of anticoagulant medications in emergency situations. It is well-tolerated and facilitates the … Read more